Condition
Neonatal Thrombocytopenia
Total Trials
5
Recruiting
2
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Recruiting2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06043050CompletedPrimary
PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia
NCT04598750RecruitingPrimary
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
NCT02802982Active Not RecruitingPrimary
Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
NCT03848923RecruitingPrimary
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
NCT03110887CompletedPrimary
Monitoring Outcome in Neonatal Thrombocytopenia
Showing all 5 trials